Profile
Esti Hayun worked as a Finance Manager at ColBar LifeScience Ltd. She then worked as a Chief Financial Officer at Geffen Residence & Renewal Ltd. and Proteologics, Inc. She also worked as a Finance Manager at Colbar R&D Ltd. and as a Chief Financial Officer at Atox Bio Ltd. Hayun holds a graduate degree from Bar-Ilan University and an undergraduate degree from The College of Management Academic Studies.
Former positions of Esti Hayun
| Companies | Position | End |
|---|---|---|
| GEFFEN RESIDENCE & RENEWAL LTD | Director of Finance/CFO | 31/12/2009 |
Proteologics, Inc. | Director of Finance/CFO | 31/12/2009 |
ColBar LifeScience Ltd.
ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering | Director of Finance/CFO | - |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Director of Finance/CFO | - |
Colbar R&D Ltd. | Director of Finance/CFO | - |
Training of Esti Hayun
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
ColBar LifeScience Ltd.
ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering | Health Technology |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Geffen Residence & Renewal Ltd.
Geffen Residence & Renewal Ltd. Agricultural Commodities/MillingProcess Industries Engages in development and marketing of medical cannabis and dried cannabis inflorescences | Process Industries |
Proteologics, Inc. | |
Colbar R&D Ltd. | |
The College of Management Academic Studies
The College of Management Academic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
- Stock Market
- Insiders
- Esti Hayun
















